Skip to main content

Table 2 Demonstrates the statistical analysis of the changes in the degrees of sexual satisfaction, prostatic volumes, post-void residual volumes, maximum urinary flow rates, and PSA levels pre and post sclerotherapy

From: Role of varicocele sclerotherapy in the management of benign prostatic hyperplasia and its associated lower urinary tract symptoms (pilot study)

  Pre Post Test value P value Sig
No. = 36 No. = 36
Post void residual volume (ml)
 Mean ± SD 124.17 ± 12.57 122.48 ± 11.57 − 1.928 0.063 NS
 Range 100–160 100–150
Prostatic volume (cc)
 Mean ± SD 68.97 ± 17.38 63.85 ± 16.63 − 1.948 0.060 NS
 Range 40–120 30–115
PSA (ng/ml)
 Median (IQR) 10 (8.5–11) 9 (8.5–10) − 1.765 0.077 NS
 Range 7–12 7–12
Q-max
 Median (IQR) 10 (9–10) 10 (8–11) − 1.607 0.108 NS
 Range 7–15 7–15
Sexual satisfaction
 Dissatisfied 17 (47.3%) 13 (36.1%) 4.337* 0.114 NS
 Neutral 16 (44.4%) 11 (30.6%)
 Satisfied 3 (8.3%) 9 (25.0%)
 NA 0 (0.0%) 3 (8.3%)
  1. P value > 0.05: non significant (NS); P value < 0.05: significant (S); P value < 0.01: highly significant (HS)
  2. Paired t-test
  3. Wilcoxon Rank test (P value > 0.05: non significant (NS); P value < 0.05: significant (S); P value < 0.01: highly significant (HS))